Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane.

Shanmugam, Mahesh P; Mythri, H M; Shetty, Nitin S

Shanmugam, Mahesh P; Mythri, H M; Shetty, Nitin S.

Indian J Ophthalmol ; 2007 Nov-Dec; 55(6): 490-1

Article in En | IMSEAR | ID: sea-69822

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Antibodies, Monoclonal/administration & dosage; Choroidal Neovascularization/drug therapy; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis/blood supply; Fundus Oculi; Humans; Injections; Middle Aged; Telangiectasis/complications; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity; Vitreous Body

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Telangiectasis / Vitreous Body / Female / Humans / Fluorescein Angiography / Visual Acuity / Follow-Up Studies / Choroidal Neovascularization / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A Type of study: Observational_studies / Prognostic_studies Language: En Journal: Indian J Ophthalmol Year: 2007 Type: Article

Fulltext

Add to My VHL

XML

Search on Google